PTC Therapeutics PTCT Enterprise value

Enterprise value at other companies

Sarepta Therapeutics, Inc.SRPT

$1.52B-2.9%

BioMarin PharmaceuticalsBMRN

$14.37B+45.5%

Capricor TherapeuticsCAPR

$1.66B+308%

ALN

Alnylam PharmaceuticalsALNY

$38.74B-6.7%

Edgewise Therapeutics, Inc.EWTX

$3.35B+63.5%

Dyne Therapeutics, Inc.DYN

$2.41B+228%

FAQ

What is PTC Therapeutics's enterprise value?

PTC Therapeutics (PTCT) reported enterprise value of $5.2B in Q1 2026.

How has PTC Therapeutics's enterprise value changed year-over-year?

PTC Therapeutics's enterprise value increased by 77.3% year-over-year, from $2.93B to $5.2B.

What is the long-term trend for PTC Therapeutics's enterprise value?

Over 5 years (2020 to 2025), PTC Therapeutics's enterprise value has grown at a 4.0% compound annual growth rate (CAGR), from $4.53B to $5.51B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.